Disclosures for "Immune Checkpoint Inhibitor (ICI) Induced Triple-M Syndrome: A Treatment Conundrum"
-
Kasyap Kondury has nothing to disclose.
-
Dr. Khan has nothing to disclose.
-
Dr. Huh-Brown has nothing to disclose.
-
Dr. Rodenbeck has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals. Dr. Rodenbeck has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Rodenbeck has received personal compensation in the range of $500-$4,999 for serving as a interview appearance with TG Therapeutics.